The Saudi Food and Drug Authority (SFDA) fined 24 pharmaceutical companies SR678400 for various infractions.
These pharmacies were unable to supply their authorised goods in the regional marketplace. These infractions include of failing to notify the SFDA of impending shortages or disruptions in supply, not keeping an acceptable quantity of their medicines on hand, and not reporting to the SFDA’s Drug Track and Trace System (RSD) in a timely manner.
According to a report released by the SFDA last month, these establishments were found to have committed five violations for failing to report directly to the RSD, nine for failing to provide their registered products, nine for failing to report anticipated shortages or supply interruptions, and one for failing to keep adequate stock of all its registered products for at least six months. The violations were observed by the establishments’ inspectors.
By “The Registration Rules of Pharmaceutical, Herbal and Health Product Manufacturers and Their Products Guideline,” the SFDA said it fined the infringing facilities SR678,400 in penalties.
These standards mandate that pharmaceutical and herbal manufacturers and warehouses maintain sufficient stock of all their registered items for six months based on annual consumption and need data assessed by the SFDA.
Also Read:
Empowering Businesses With Ultimate Payment Solutions With Pine Labs: Dounia Jouron
Advancing HSE Management with ASSP – Kuwait Chapter: Bader Al-Hadhrami
